SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-24-005904
Filing Date
2024-04-26
Accepted
2024-04-26 16:10:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20240426xdefa14a.htm DEFA14A 16654
2 GRAPHIC tmb-20240426xdefa14a_bg001.jpg GRAPHIC 211464
3 GRAPHIC tmb-20240426xdefa14a_bg002.jpg GRAPHIC 149656
  Complete submission text file 0001558370-24-005904.txt   515298
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37719 | Film No.: 24883747
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)